Lazard Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
|
|||||
|
2025
Q1 | $1.86M | Sell |
|
|||||
|
2024
Q4 | $2.72M | Sell |
|
|||||
|
2024
Q3 | $2.85M | Buy |
|
|||||
|
2024
Q2 | $3.23M | Sell |
|
|||||
|
2024
Q1 | $9.15M | Sell |
|
|||||
|
2023
Q4 | $19.5M | Buy |
|
|||||
|
2023
Q3 | $14.5M | Sell |
|
|||||
|
2023
Q2 | $21.2M | Buy |
|
|||||
|
2023
Q1 | $24.5M | Buy |
|
|||||
|
2022
Q4 | $29.4M | Sell |
|
|||||
|
2022
Q3 | $32.5M | Sell |
|
|||||
|
2022
Q2 | $35.6M | Buy |
|
|||||
|
2022
Q1 | $31.1M | Buy |
|
|||||
|
2021
Q4 | $4.16M | Buy |
|
|||||
|
2021
Q3 | $2.83M | Buy |
|